Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR-40.4%
Studio
Year-over-Year Change

Year-over-year net income growth rate

5Y CAGR
-40.4%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025107.07%
2024-337.30%
2023163.72%
2022-62.10%
2021-71.15%
20201421.01%
2019-2238.85%
201898.89%
2017-12.28%
2016-2144.67%